Test Price
2,800 AED✅ Home Collection Available
FGF10 Gene LADD Syndrome Genetic Test – 2,800 AED – DNA Labs UAE
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Targeted NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Dedicated telephonic post-test genetic counseling and result interpretation by our Consultant Medical Geneticist.
- Insurance Support: Direct Billing Verification available via WhatsApp at +971 54 548 8731.
Executive Summary & Core Metrics
DNA Labs UAE offers the FGF10 Gene LADD Syndrome Genetic Test, a high-precision diagnostic sequencing assay for detecting pathogenic variants associated with Lacrimo-Auriculo-Dento-Digital (LADD) Syndrome. This test is exclusively conducted within our accredited Dubai Healthcare City facility (DHA License: 1143) under the clinical oversight of Consultant Medical Geneticist Lina Osama Zaki Quteineh (DHA ID: 9294403).
Test Overview & Methodology
This advanced test utilizes targeted next-generation sequencing (NGS) to analyze the FGF10 gene for mutations known to cause LADD syndrome. It provides a definitive molecular diagnosis for patients presenting with characteristic dysmorphic features involving the lacrimal, auricular, and dental systems.
| Feature | Our Test (FGF10 Targeted NGS) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for FGF10 coding and splice-site variants | ~95% coverage; may miss deep intronic or copy number variants in FGF10 |
| Methodology | Targeted NGS on Illumina NovaSeq X platform, 100x mean depth | Whole Exome Sequencing with variable coverage depth |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Cost | 2,800 AED | 4,500 – 6,000 AED |
Physician Insight & Safety Protocols
Clinical Perspective from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403): “The FGF10 gene analysis is a targeted diagnostic step and must be interpreted within the broader context of the patient’s full phenotypic features and three-generation family pedigree. A negative sequencing result does not entirely exclude a genetic etiology, and ongoing clinical correlation remains essential for comprehensive patient management.”
Pre-Test and Post-Test Advisory
This test requires a formal clinical referral from a licensed physician. All results are accompanied by a mandatory telephonic consultation with our genetic counseling team to discuss clinical implications, family risk, and long-term management strategies.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Not indicated for individuals without a clinical suspicion of LADD syndrome or for acute, undiagnosed medical crises.
- Exclusion: This test must not be used as a stand-alone screening tool without pre- and post-test genetic counseling.
- ER Red Flag: Seek immediate emergency care if the patient develops severe developmental regression, recurrent aspiration pneumonia, or acute respiratory distress.
Patient FAQ & Clinical Guidance
1. What is the FGF10 LADD syndrome genetic test used for?
This test identifies pathogenic mutations in the FGF10 gene to confirm a clinical diagnosis of LADD syndrome in patients presenting with characteristic dysmorphic features of the lacrimal, auricular, and dental systems.
2. How accurate is the NGS testing for FGF10 mutations?
With a validated diagnostic sensitivity of 99.9% on the Illumina NovaSeq X platform, our targeted NGS approach ensures near-complete detection of pathogenic variants in the FGF10 coding and splice-site regions.
3. How long does it take to receive my results?
Your comprehensive FGF10 NGS report will be ready within 3 to 4 weeks from the date of sample receipt. Preliminary findings may be available earlier and will be discussed during your follow-up consultation.
4. When is this test clinically warranted?
This test is clinically warranted for individuals with a suspected diagnosis of LADD syndrome based on clinical findings, family history, or unexplained congenital anomalies affecting the face, ears, teeth, or digits.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is anonymized, encrypted, and stored on secure UAE-based servers. Patient consent protocols comply fully with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring ethical and legal integrity throughout the diagnostic pathway.
Clinical & Logistical Metadata
| Test Name | FGF10 Gene LADD Syndrome Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Buccal Swab (Standard Venipuncture – VIP Mobile Phlebotomy Eligible) |
| Methodology Used | Targeted NGS (Illumina NovaSeq X Platform, 100x Coverage) |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 82255-5 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians